Flovent and Kalbitor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flovent (fluticasone propionate) and Kalbitor (ecallantide). Common drug interactions include migraine among females and hereditary angioedema among males.

The phase IV clinical study analyzes what interactions people have when they take Flovent and Kalbitor. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Flovent?

Flovent has active ingredients of fluticasone propionate. It is often used in asthma. eHealthMe is studying from 44,817 Flovent users. Check the latest studies of Flovent.

What is Kalbitor?

Kalbitor has active ingredients of ecallantide. eHealthMe is studying from 2,079 Kalbitor users. Check the latest studies of Kalbitor.



On Jul, 28, 2026

20 people who take Flovent and Kalbitor together, and have interactions are studied.

Flovent and Kalbitor drug interactions.

What are the common drug interactions of Flovent and Kalbitor, by gender? *:

female:

  1. Migraine (headache)
  2. Vomiting
  3. Infusion related reaction
  4. Nausea (feeling of having an urge to vomit)
  5. Stress
  6. Foot fracture
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Upper limb fracture
  10. Weight decreased

male:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Interstitial lung disease

What are the common drug interactions of Flovent and Kalbitor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Migraine (headache)
  2. Vomiting
  3. Abdominal distension
  4. Abdominal pain upper
  5. Dyspnoea (difficult or laboured respiration)
  6. Dysuria (painful or difficult urination)
  7. Headache (pain in head)
  8. Nausea (feeling of having an urge to vomit)
  9. Dehydration (dryness resulting from the removal of water)
  10. Hereditary angioedema (recurrent episodes of severe swelling)

50-59:

n/a

60+:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Nausea (feeling of having an urge to vomit)
  5. Vomiting
  6. Sinusitis (inflammation of sinus)
  7. Upper respiratory tract infection
  8. Interstitial lung disease

What are the existing conditions these people have? *

  1. Hereditary Angioedema (recurrent episodes of severe swelling): 16 people, 80.00%
  2. Pain: 8 people, 40.00%
  3. Immune System Disorder: 8 people, 40.00%
  4. Nausea (feeling of having an urge to vomit): 7 people, 35.00%
  5. Wheezing (a high-pitched whistling sound made while you breath): 4 people, 20.00%
  6. Back Pain: 4 people, 20.00%
  7. Migraine (headache): 4 people, 20.00%
  8. Stress And Anxiety: 3 people, 15.00%
  9. Depression: 2 people, 10.00%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Flovent and Kalbitor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flovent and Kalbitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flovent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Kalbitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flovent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kalbitor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate and ecallantide (the active ingredients of Flovent and Kalbitor, respectively), and Flovent and Kalbitor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: